HEADER TRANSFERASE/TRANSFERASE INHIBITOR 11-JUL-14 4U0I TITLE CRYSTAL STRUCTURE OF KIT IN COMPLEX WITH PONATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL COMPND 3 GROWTH FACTOR RECEPTOR KIT; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 563-693 AND 754-935 LINKED VIA LINKER (THR COMPND 6 SER); COMPND 7 SYNONYM: SCFR,PIEBALD TRAIT PROTEIN,PBT,PROTO-ONCOGENE C-KIT, COMPND 8 TYROSINE-PROTEIN KINASE KIT,P145 C-KIT,V-KIT HARDY-ZUCKERMAN 4 FELINE COMPND 9 SARCOMA VIRAL ONCOGENE HOMOLOG,SCFR,PIEBALD TRAIT PROTEIN,PBT,PROTO- COMPND 10 ONCOGENE C-KIT,TYROSINE-PROTEIN KINASE KIT,P145 C-KIT,V-KIT HARDY- COMPND 11 ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; COMPND 12 EC: 2.7.10.1; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIT, SCFR; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KIT, RECEPTOR TYROSINE KINASE, INHIBITOR, PONATINIB, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.ZHOU,X.ZHU,D.C.DALGARNO REVDAT 4 27-DEC-23 4U0I 1 COMPND REMARK HETNAM REVDAT 3 22-NOV-17 4U0I 1 SOURCE REMARK REVDAT 2 26-NOV-14 4U0I 1 JRNL REVDAT 1 08-OCT-14 4U0I 0 JRNL AUTH A.P.GARNER,J.M.GOZGIT,R.ANJUM,S.VODALA,A.SCHROCK,T.ZHOU, JRNL AUTH 2 C.SERRANO,G.EILERS,M.ZHU,J.KETZER,S.WARDWELL,Y.NING,Y.SONG, JRNL AUTH 3 A.KOHLMANN,F.WANG,T.CLACKSON,M.C.HEINRICH,J.A.FLETCHER, JRNL AUTH 4 S.BAUER,V.M.RIVERA JRNL TITL PONATINIB INHIBITS POLYCLONAL DRUG-RESISTANT KIT JRNL TITL 2 ONCOPROTEINS AND SHOWS THERAPEUTIC POTENTIAL IN HEAVILY JRNL TITL 3 PRETREATED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS. JRNL REF CLIN.CANCER RES. V. 20 5745 2014 JRNL REFN ISSN 1078-0432 JRNL PMID 25239608 JRNL DOI 10.1158/1078-0432.CCR-14-1397 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 3.14 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 24107 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1164 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2356 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 137 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09600 REMARK 3 B22 (A**2) : -0.09600 REMARK 3 B33 (A**2) : 0.19300 REMARK 3 B12 (A**2) : 0.07800 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.135 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.753 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.854 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.605 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : AP24534_KIT.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4U0I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000202573. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25483 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 8.200 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.69400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.5, 0.9-1.2M AMMONIUM REMARK 280 SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.14133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.07067 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 43.07067 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 86.14133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 563 REMARK 465 ASN A 564 REMARK 465 LYS A 613 REMARK 465 SER A 614 REMARK 465 ASP A 615 REMARK 465 LYS A 751 REMARK 465 THR A 752 REMARK 465 SER A 753 REMARK 465 PRO A 754 REMARK 465 ALA A 755 REMARK 465 ILE A 756 REMARK 465 MET A 757 REMARK 465 GLU A 758 REMARK 465 ASP A 759 REMARK 465 ASP A 760 REMARK 465 GLU A 761 REMARK 465 HIS A 934 REMARK 465 ILE A 935 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLY A 565 O HOH A 1101 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 791 -20.01 79.28 REMARK 500 ASN A 828 50.49 -109.23 REMARK 500 ASP A 876 -167.70 -170.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0LI A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 1003 DBREF 4U0I A 563 751 UNP P10721 KIT_HUMAN 563 693 DBREF 4U0I A 754 935 UNP P10721 KIT_HUMAN 754 935 SEQADV 4U0I THR A 752 UNP P10721 LINKER SEQADV 4U0I SER A 753 UNP P10721 LINKER SEQRES 1 A 315 ILE ASN GLY ASN ASN TYR VAL TYR ILE ASP PRO THR GLN SEQRES 2 A 315 LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO ARG ASN ARG SEQRES 3 A 315 LEU SER PHE GLY LYS THR LEU GLY ALA GLY ALA PHE GLY SEQRES 4 A 315 LYS VAL VAL GLU ALA THR ALA TYR GLY LEU ILE LYS SER SEQRES 5 A 315 ASP ALA ALA MET THR VAL ALA VAL LYS MET LEU LYS PRO SEQRES 6 A 315 SER ALA HIS LEU THR GLU ARG GLU ALA LEU MET SER GLU SEQRES 7 A 315 LEU LYS VAL LEU SER TYR LEU GLY ASN HIS MET ASN ILE SEQRES 8 A 315 VAL ASN LEU LEU GLY ALA CYS THR ILE GLY GLY PRO THR SEQRES 9 A 315 LEU VAL ILE THR GLU TYR CYS CYS TYR GLY ASP LEU LEU SEQRES 10 A 315 ASN PHE LEU ARG ARG LYS ARG ASP SER PHE ILE CYS SER SEQRES 11 A 315 LYS THR SER PRO ALA ILE MET GLU ASP ASP GLU LEU ALA SEQRES 12 A 315 LEU ASP LEU GLU ASP LEU LEU SER PHE SER TYR GLN VAL SEQRES 13 A 315 ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS ILE SEQRES 14 A 315 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR HIS SEQRES 15 A 315 GLY ARG ILE THR LYS ILE CYS ASP PHE GLY LEU ALA ARG SEQRES 16 A 315 ASP ILE LYS ASN ASP SER ASN TYR VAL VAL LYS GLY ASN SEQRES 17 A 315 ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE SEQRES 18 A 315 PHE ASN CYS VAL TYR THR PHE GLU SER ASP VAL TRP SER SEQRES 19 A 315 TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SER SEQRES 20 A 315 SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE TYR SEQRES 21 A 315 LYS MET ILE LYS GLU GLY PHE ARG MET LEU SER PRO GLU SEQRES 22 A 315 HIS ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR CYS SEQRES 23 A 315 TRP ASP ALA ASP PRO LEU LYS ARG PRO THR PHE LYS GLN SEQRES 24 A 315 ILE VAL GLN LEU ILE GLU LYS GLN ILE SER GLU SER THR SEQRES 25 A 315 ASN HIS ILE HET 0LI A1001 39 HET PO4 A1002 5 HET PO4 A1003 5 HETNAM 0LI 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4- HETNAM 2 0LI [(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL) HETNAM 3 0LI PHENYL}BENZAM IDE HETNAM PO4 PHOSPHATE ION HETSYN 0LI PONATINIB FORMUL 2 0LI C29 H27 F3 N6 O FORMUL 3 PO4 2(O4 P 3-) FORMUL 5 HOH *137(H2 O) HELIX 1 AA1 ASP A 572 LEU A 576 5 5 HELIX 2 AA2 ASP A 579 GLU A 583 5 5 HELIX 3 AA3 PRO A 585 ASN A 587 5 3 HELIX 4 AA4 HIS A 630 GLY A 648 1 19 HELIX 5 AA5 ASP A 677 ARG A 686 1 10 HELIX 6 AA6 ASP A 687 PHE A 689 5 3 HELIX 7 AA7 ASP A 765 LYS A 786 1 22 HELIX 8 AA8 ALA A 794 ARG A 796 5 3 HELIX 9 AA9 PHE A 811 ARG A 815 5 5 HELIX 10 AB1 PRO A 832 MET A 836 5 5 HELIX 11 AB2 ALA A 837 CYS A 844 1 8 HELIX 12 AB3 THR A 847 SER A 864 1 18 HELIX 13 AB4 ASP A 876 GLY A 886 1 11 HELIX 14 AB5 PRO A 896 TRP A 907 1 12 HELIX 15 AB6 ASP A 910 ARG A 914 5 5 HELIX 16 AB7 THR A 916 SER A 931 1 16 SHEET 1 AA1 5 LEU A 589 ALA A 597 0 SHEET 2 AA1 5 GLY A 601 TYR A 609 -1 O VAL A 603 N LEU A 595 SHEET 3 AA1 5 ALA A 617 LEU A 625 -1 O MET A 618 N ALA A 608 SHEET 4 AA1 5 LEU A 667 GLU A 671 -1 O THR A 670 N ALA A 621 SHEET 5 AA1 5 LEU A 656 CYS A 660 -1 N LEU A 657 O ILE A 669 SHEET 1 AA2 2 ILE A 798 THR A 801 0 SHEET 2 AA2 2 ILE A 805 ILE A 808 -1 O LYS A 807 N LEU A 799 SHEET 1 AA3 2 VAL A 824 VAL A 825 0 SHEET 2 AA3 2 ARG A 830 LEU A 831 -1 O LEU A 831 N VAL A 824 SITE 1 AC1 22 LEU A 595 ALA A 621 VAL A 622 LYS A 623 SITE 2 AC1 22 GLU A 640 LEU A 647 ILE A 653 VAL A 654 SITE 3 AC1 22 THR A 670 GLU A 671 TYR A 672 CYS A 673 SITE 4 AC1 22 CYS A 788 ILE A 789 HIS A 790 ARG A 791 SITE 5 AC1 22 LEU A 799 ILE A 808 CYS A 809 ASP A 810 SITE 6 AC1 22 PHE A 811 HOH A1204 SITE 1 AC2 7 LYS A 642 TYR A 675 HIS A 802 GLY A 803 SITE 2 AC2 7 LYS A 913 HOH A1138 HOH A1188 SITE 1 AC3 7 THR A 619 TYR A 672 CYS A 674 HIS A 802 SITE 2 AC3 7 HOH A1105 HOH A1132 HOH A1193 CRYST1 70.032 70.032 129.212 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014279 0.008244 0.000000 0.00000 SCALE2 0.000000 0.016488 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007739 0.00000